Fibrinolysis in cholestatic jaundice

Area of Science:

• Hepatology
• Hematology
• Biochemistry

Background:

• The fibrinolytic system is crucial for regulating blood clot breakdown.
• Cholestatic liver diseases like primary biliary cirrhosis and bile duct obstruction can affect coagulation and fibrinolysis.
• Understanding these alterations is vital for assessing thrombosis risk.

Purpose of the Study:

• To investigate the fibrinolytic system in patients with primary biliary cirrhosis and large bile duct obstruction.
• To correlate fibrinolytic changes with the degree of cholestasis and lipid metabolism.
• To evaluate the impact of surgical intervention on fibrinolysis.

Main Methods:

• Assessed plasma fibrinolysis (plasminogen activator activity) and fibrinogen levels in patients.
• Measured urokinase inhibitors, antiplasmins, and fibrin/fibrinogen degradation products.
• Correlated fibrinolytic indices with serum triglyceride levels and degree of cholestasis.

Main Results:

• Decreased plasma fibrinolysis and increased fibrinogen were observed in both patient groups, more pronounced in large duct obstruction.
• Plasminogen activator activity showed an inverse relationship with serum triglycerides in primary biliary cirrhosis.
• Fibrinolytic activity and fibrinogen normalized post-surgery in a small subset of patients.

Conclusions:

• Altered lipid metabolism in cholestatic jaundice may cause decreased plasma fibrinolysis and increased fibrinogen.
• Patients with large bile duct obstruction undergoing surgery may face an elevated risk of thrombosis.
• Further research is needed to elucidate the precise mechanisms linking cholestasis, lipid metabolism, and fibrinolysis.